PROMOTING from within the company, GlaxoSmithKline (GSK) has appointed Emma Walmsley as its first female ceo, replacing Andrew Witty when he retires.
Witty has served in the role since 2008 and retires on 31 Mar 2017.
Walmsley has led GSK's consumer healthcare division since it was formed last year following the company's completion of a three-part transaction with Novartis, and has been a member of the company's executive team since 2011.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Mar 17